Abstract:BackgroundThis paper presents the use of Support Vector Machines (SVMs) for prediction and analysis of antisense oligonucleotide (AO) efficacy. The collected database comprises 315 AO molecules including 68 features each, inducing a problem well-suited to SVMs. The task of feature selection is crucial given the presence of noisy or redundant features, and the well-known problem of the curse of dimensionality. We propose a two-stage strategy to develop an optimal model: (1) feature selection using correlation analysis, mutual information, and SVM-based recursive feature elimination (SVM-RFE), and (2) AO prediction using standard and profiled SVM formulations. A profiled SVM gives different weights to different parts of the training data to focus the training on the most important regions.ResultsIn the first stage, the SVM-RFE technique was most efficient and robust in the presence of low number of samples and high input space dimension. This method yielded an optimal subset of 14 representative features, which were all related to energy and sequence motifs. The second stage evaluated the performance of the predictors (overall correlation coefficient between observed and predicted efficacy, r; mean error, ME; and root-mean-square-error, RMSE) using 8-fold and minus-one-RNA cross-validation methods. The profiled SVM produced the best results (r = 0.44, ME = 0.022, and RMSE= 0.278) and predicted high (>75% inhibition of gene expression) and low efficacy (<25%) AOs with a success rate of 83.3% and 82.9%, respectively, which is better than by previous approaches. A web server for AO prediction is available online at http://aosvm.cgb.ki.se/.ConclusionsThe SVM approach is well suited to the AO prediction problem, and yields a prediction accuracy superior to previous methods. The profiled SVM was found to perform better than the standard SVM, suggesting that it could lead to improvements in other prediction problems as well.

Study Of E-Smooth Support Vector Regression And Comparison With E- Support Vector Regression And Potential Support Vector Machines For Prediction For The Antitubercular Activity Of Oxazolines And Oxazoles Derivatives

A Novel Robust Smooth Support Vector Machine

Fuzzy Support Vector Regression Model of 4-CBA Concentration for Industrial PTA Oxidation Process

Weighted Support Vector Machines for Regression and Its Application

Optimization of Molecular Docking Scores with Support Vector Rank Regression

Performance Analysis Of Regularized Linear Regression Models For Oxazolines And Oxazoles Derivitive Descriptor Dataset

Iterative robust least square support vector machine for spectral analysis

M-estimator Based Support Vector Machine and Its Application

Predicting Anti‐HIV‐1 Activities of HEPT‐analog Compounds by Using Support Vector Classification

Important Molecular Descriptors Selection Using Self Tuned Reweighted Sampling Method for Prediction of Antituberculosis Activity

Classification of Src Kinase Inhibitors Based on Support Vector Machine

Using support vector regression for QSAR study on the aldose reductase inhibitory activity of some flavones

Profiled support vector machines for antisense oligonucleotide efficacy prediction

Comparison of V-Support Vector Regression and Logistic Equation for Descriptive Modeling of Lactobacillus Plantarum Growth

Support Vector Machine Classification and Regression Prioritize Different Structural Features for Binary Compound Activity and Potency Value Prediction

Prediction of Torsade-Causing Potential of Drugs by Support Vector Machine Approach

Prediction of the Aquatic Toxicity of Aromatic Compounds to Tetrahymena Pyriformis Through Support Vector Regression

Evolution of Support Vector Machine and Regression Modeling in Chemoinformatics and Drug Discovery

Predicting anti-trypanosome effect of carbazole-derived compounds by powerful SVM with novel kernel function and comprehensive learning PSO

Construction of a new smooth support vector machine model and its application in heart disease diagnosis

Predictive Comparative QSAR analysis of Sulfathiazole Analogues as Mycobacterium Tuberculosis H37RV Inhabitors